Capitolis Liquid Global Markets LLC Buys New Holdings in Amprius Technologies, Inc. $AMPX

Capitolis Liquid Global Markets LLC acquired a new stake in Amprius Technologies, Inc. (NYSE:AMPX) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 680,600 shares of the company’s stock, valued at approximately $7,160,000. Capitolis Liquid Global Markets LLC owned approximately 0.52% of Amprius Technologies as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Jones Financial Companies Lllp raised its holdings in shares of Amprius Technologies by 353.2% in the 3rd quarter. Jones Financial Companies Lllp now owns 4,532 shares of the company’s stock worth $50,000 after buying an additional 3,532 shares in the last quarter. Parallel Advisors LLC acquired a new stake in Amprius Technologies in the 3rd quarter valued at $54,000. Geneos Wealth Management Inc. acquired a new stake in Amprius Technologies in the 3rd quarter valued at $74,000. Ameritas Investment Partners Inc. grew its position in Amprius Technologies by 2,043.2% in the second quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock valued at $40,000 after acquiring an additional 9,072 shares during the period. Finally, Legal & General Group Plc grew its position in Amprius Technologies by 1,385.4% in the second quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock valued at $44,000 after acquiring an additional 9,684 shares during the period. 5.04% of the stock is owned by institutional investors.

Insider Transactions at Amprius Technologies

In other Amprius Technologies news, Director Wen Hsuan Hsieh sold 413,146 shares of the business’s stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $18.44, for a total transaction of $7,618,412.24. Following the completion of the sale, the director directly owned 44,444 shares of the company’s stock, valued at approximately $819,547.36. The trade was a 90.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Steven Chu sold 155,565 shares of the company’s stock in a transaction dated Thursday, March 12th. The shares were sold at an average price of $18.50, for a total transaction of $2,877,952.50. Following the transaction, the director owned 127,339 shares in the company, valued at approximately $2,355,771.50. The trade was a 54.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 2,929,357 shares of company stock valued at $37,783,110. 12.80% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. William Blair reiterated an “outperform” rating on shares of Amprius Technologies in a research report on Friday, March 6th. Craig Hallum boosted their price target on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a research report on Friday, March 6th. Needham & Company LLC reaffirmed a “buy” rating and set a $20.00 price objective on shares of Amprius Technologies in a report on Tuesday, March 10th. Oppenheimer reiterated an “outperform” rating and issued a $17.00 target price on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Amprius Technologies in a research report on Wednesday, January 21st. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $19.75.

Amprius Technologies Stock Performance

NYSE AMPX opened at $17.93 on Monday. The stock has a fifty day moving average of $11.88 and a 200-day moving average of $11.12. The stock has a market capitalization of $2.46 billion, a P/E ratio of -52.72 and a beta of 3.04. Amprius Technologies, Inc. has a 52 week low of $1.80 and a 52 week high of $19.40.

Amprius Technologies (NYSE:AMPX) last released its earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.The company had revenue of $25.23 million during the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. Equities research analysts forecast that Amprius Technologies, Inc. will post -0.45 earnings per share for the current fiscal year.

Key Stories Impacting Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Northland Securities raised Q1 EPS estimates for AMPX, improving near-term earnings visibility and giving bulls a fundamental reason to buy. Q1 EPS Estimates for AMPX Increased by Northland Securities
• Positive Sentiment: Needham & Company reaffirmed its Buy rating on AMPX (and other brokers have raised targets or reiterated buys), adding analyst-level validation that can attract institutional and retail inflows. Needham & Company LLC Reaffirms Buy Rating for Amprius Technologies (NYSE:AMPX)
• Neutral Sentiment: Coverage summarizing Northland’s forecast for AMPX Q4 earnings provides modeling context for investors but is informational until tied to company guidance or additional upgrades. What is Northland Securities’ Forecast for AMPX Q4 Earnings?
• Negative Sentiment: Director Steven Chu sold 155,565 shares on March 12 at an average price of $18.50 (~$2.88M), cutting his holdings by roughly 55% — a large insider sale that can be interpreted as a negative signal and may create short-term downward pressure. SEC Filing: Steven Chu Sale (3/12)
• Negative Sentiment: On March 10 the same director sold another 166,632 shares at an average of $17.92 (~$2.99M). The consecutive large sales amplify the negative signaling despite possible non-operational reasons (tax, diversification). SEC Filing: Steven Chu Sale (3/10)

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.